Physicians "Get Smart" - Number of Docs Using Smartphones Surges to 64% in 2009

Manhattan ResearchIn 2009, the number of physicians using smartphones surged to 64%, according to Taking the Pulse® v9.0, pharmaceutical and healthcare market research company Manhattan Research's newly released study focused on physician adoption, use, and impact of the Internet and other technologies. This group of "smart" physicians using mobile devices such as iPhones and BlackBerries increased by 20% between 2008 and 2009. In fact, the number of physicians using iPhones more than doubled in the past year alone.

Survey results indicate that physicians' increased reliance on smartphones is not cannibalizing Internet usage on computers. Rather, physicians are spending more time online overall and are using both computers and smartphones to access to the most up-to-date online medical and pharmaceutical resources at a variety of points throughout the day. Additionally, smartphone-using physicians are an important group to take note of for strategy planning, especially for brand teams looking to leverage the evolving physician media mix in building relationships with their target audiences.

"Physicians have always been advanced in terms of their mobile use", said Monique Levy, Senior Director of Research at Manhattan Research, "Nevertheless, growth in smartphone ownership in the last year is remarkable. Mobile is delivering on its promise to allow doctors to be 'always on' - which is partly why so many doctors say the Internet is essential to their practice."

Sign up for the Taking the Pulse® v9.0 Webinar
Date: Tuesday, April 21, 2009 at 11am and 3pm EDT

Manhattan Research Senior Director of Research Monique Levy will discuss the latest trends in U.S. physician use of the Internet, mobile devices, social networking, and other technologies from the newly released Taking the Pulse® v9.0 physician study and advisory service.

This year's study reveals critical shifts in the physician media mix for professional and pharma information-seeking, making the webinar a valuable session for product managers and marketers planning strategies for connecting with physicians in 2010 and beyond.

Key topics include physician trends related to the Internet, Web 2.0 technologies, email communication, PDAs/smartphones, search engines, detailing/tech-enabled sales reps, patient interaction/education, and digital health infrastructure.

Session 1: Tuesday, April 21, 11:00am EDT
Sign up here: https://www2.gotomeeting.com/register/576156547

Session 2: Tuesday, April 21, 3:00pm EDT
Sign up here: https://www2.gotomeeting.com/register/271553794

For assistance signing up for the above sessions, please contact Maureen Malloy at This email address is being protected from spambots. You need JavaScript enabled to view it. or 212-255-7799.

About Taking the Pulse® v9.0
Taking the Pulse® v9.0 is a market research and strategic advisory service focused on which technologies physicians have adopted, how they are currently using them, and how they plan to use them in the future. The study was conducted in Q1 2009 among a nationally representative sample of 1,900 practicing U.S. physicians.

Clients can further segment the broad physician market trends to derive statistically relevant insight across the following specialties: Allergists, Cardiologists, Dermatologists, Electro Physiologists, Emergency Medicine, Endocrinologists, Gastroenterologists, Surgeons, Hematology Oncologists, Infectious Disease Specialists, Medical Oncologists, Nephrologists, Neurologists, Obstetrics/Gynecologists (OB/GYNs), Ophthalmologists, Orthopedic Surgeons, Pediatricians, Primary Care Physicians (General Practice, Family Practice and Internal Medicine), Psychiatrists, Pulmonologists, Radiologists, Rheumatologists and Urologists.

In addition to the data, clients receive strategic deliverables including research reports, client briefings, and access to the Manhattan Research analyst team to answer specific questions.

For additional product and subscription information, please visit http://www.manhattanresearch.com/products/Strategic_Advisory/ttp/

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.

Most Popular Now

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...

GSK announces positive Phase IIa study results for…

GSK plc (LSE/NYSE: GSK) announced positive results from a Phase IIa study demonstrating that GSK3036656, a first-in-class investigational antitubercular agent, was well t...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

Unusual type of antibody shows ultrapotent activit…

An unusual type of antibody that even at miniscule levels neutralizes the Zika virus and renders the virus infection undetectable in preclinical models has been identifie...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Machine learning can help predict patient response…

Predicting which patients will respond well to treatment is a quandary that has plagued the field of cancer immunotherapy for more than four decades. Now, researchers at ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...